Safety Study of XT-150 in Participants With ALS

Clinical trial NCT06704347 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06704347
Sponsor: Xalud Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2027-03-01
Primary completion: 2028-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.